Health Care/Hospital

Bringing Enhanced Cancer Care to Singapore with Varian's Halcyon System

PALO ALTO, Calif., and SINGAPORE, Sept. 7, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced that Proton Therapy Pte. Ltd. has placed an order for a Halcyon system, making them the first to bring this innovative treatment platform intoSingapore, with the aim of treating the first patient by...

2020-09-07 07:00 7394

Executive from Yuyu Pharma Receives Presidential Commendation for Gender Equality Employment

SEOUL, South Korea, Sept. 4, 2020 /PRNewswire/ -- Eugene Baik, Head of Production at Yuyu Pharma (CEORobert Wonsang Yu, KRX 000220), received the Presidential Commendation for contributions in leading the realization of gender equality employment. The award was given at the 2020 Gender Equality ...

2020-09-04 21:00 2799

I-Mab Announces $418 Million Private Placement with Hillhouse Capital-Led Consortium

SHANGHAI and GAITHERSBURG, Md., Sept. 4, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that it has entered into definitive subscription agreeme...

2020-09-04 19:01 10043

AbbVie and I-Mab Enter into Global Strategic Partnership for Differentiated Immuno-oncology Therapy

NORTH CHICAGO, Illinois and SHANGHAI, China, Sept. 4, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) and I-Mab (Nasdaq: IMAB) announced today that AbbVie and I-Mab have signed a broad, global collaboration agreement for the development and commercialization of lemzoparlimab (also known as TJC4), an inn...

2020-09-04 19:00 9463

Otis Commissions Study on Elevator Airflow Amid COVID-19 Pandemic

* Independent study to investigate risk of airborne transmission in elevators * Findings aim to advance industry safety protocols and provide additional scientific data to inform riding public * Led by Purdue University expert TAIPEI and HONG KONG, Sept. 4, 2020 /PRNewswire/ --  Otis Worldwi...

2020-09-04 18:37 10603

111, Inc. Partners with Baiyunshan Pharmaceutical Sales in Digital Medicine Innovation

SHANGHAI, Sept. 4, 2020 /PRNewswire/ -- On August 25, 111, Inc. ("111" or the "Company") (Nasdaq: YI), a company dedicated to digitally connecting patients with drugs and healthcare services inChina, and Guangzhou Baiyunshan Pharmaceutical Sales Co., Ltd. ("Baiyunshan Pharmaceutical Sales"), an ...

2020-09-04 18:22 8887

RhoVac appoints Professor Georg Hollaender to its Scientific Advisory Board

STOCKHOLM, Sept. 4, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today September 4th 2020,  that it is continuing to strengthen the Scientific Advisory Board with a pediatric immunologist, by appointing ProfessorGeorg Hollaender, Action Research Professor and Head of Department at Oxford ...

2020-09-04 17:35 2957

Nippon Express USA Acquires GDP Certification for Chicago Warehouse

TOKYO, Sept. 4, 2020 /PRNewswire/ -- Nippon Express USA, Inc. (hereinafter, "NE USA"), a local subsidiary of Nippon Express Co., Ltd. based inTokyo, has recently set up NEX Pharma Solutions-Chicago, a temperature-controlled facility specializing in medical and pharmaceutical products, within its ...

2020-09-04 13:00 2918

InxMed Announced the Completion of RMB 130M (~US$ 19M) Series A+ Financing to Accelerate Its Clinical Development and Strengthen Translational Capabilities

NANJING, China, Sept. 4 2020 /PRNewswire/ -- InxMed (Nanjing) Co., Ltd. ("InxMed" or "Company"), a clinical stage biotech company dedicated to developing innovative, individualized medicines with international impact, today announced the completion of its Series A+ financing of130M RMB ( ~US$19Mi...

2020-09-04 11:24 1408

First COVID-19 Global Forecast: IHME Projects Three-Quarters of a Million Lives Could be Saved by January 1

SEATTLE, Sept. 4, 2020 /PRNewswire/ -- In the first global projections of the COVID-19 pandemic by nation, the Institute for Health Metrics and Evaluation (IHME) at theUniversity of Washington's School of Medicine is predicting nearly 770,000 lives worldwide could be saved between now andJanuary ...

2020-09-04 10:49 2811

ATrack's UVengers UV1 verified by Chang Gung University to kill 99.8% of SARS-CoV-2 in 3 seconds

TAIPEI, Sept. 4, 2020 /PRNewswire/ -- ATrack Technology Inc. (TPEX: 6465), an Internet of Vehicles (IoV) company, has established the new brand UVengers that provides disease prevention products to help people stay safe from pathogen-related illnesses during the current pandemic and in the post-p...

2020-09-04 08:00 2909

ezyVet and Openpay enter strategic partnership to extend payment plans to fur babies

AUCKLAND, New Zealand, Sept. 4, 2020 /PRNewswire/ -- Thanks to a new partnership between 'Buy Now Pay Later' (BNPL) payment providerOpenpay (ASX: OPY), and veterinary software provider ezyVet , pet owners can now spread the cost of their vet ...

2020-09-04 07:17 2974

American Neurological Association Hosts First-Ever All-Virtual Annual Meeting

MOUNT LAUREL, New Jersey, Sept. 4 2020 /PRNewswire/ -- On October 4-9, 2020, the American Neurological Association, for the first time in its 145-year history, is moving from a traditional meeting format to an interactive, virtual meeting experience. As always, the meeting will explore the latest...

2020-09-04 02:38 2767

Infosys to Acquire Product Design and Development firm, Kaleidoscope Innovation

Expands engineering services portfolio by strengthening presence in Medical devices, Consumer and Industrial markets across US BENGALURU, India and CINCINNATI, Sept. 4, 2020 /PRNewswire/ -- Infosys  (NYSE: INFY), a global leader in next-generation digital services and c...

2020-09-04 02:36 26784

Alphamab Oncology announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to KN046 for the treatment of thymic epithelial tumor

SUZHOU, China, Sept. 3, 2020 /PRNewswire/ -- Alphamab Oncology (stock code: 9966 HK) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to KN046, a recombinant humanized PD-L1/CTLA-4 bispecific antibody developed by Jiangsu Alphamab Biopharmaceuti...

2020-09-03 23:46 1313

As More Seniors Look to Age Independently, TCL Unveils the MOVETIME Family Watch to Help Keep Seniors Connected

BERLIN, Sept. 3, 2020 /PRNewswire/ -- TCL, one of the world's best-selling consumer electronics brands and leading technology companies, is introducing the MOVETIME Family Watch MT43A today. This 4G connected watch provides hands-free two way calling, automatic fall detection, heart rate monitori...

2020-09-03 21:15 9622

Merck to Showcase New Data at ACTRIMS-ECTRIMS MSVirtual2020 Meeting, Furthering Innovation in Multiple Sclerosis

Not intended for UK and US based media - Company to present 54 abstracts across its MS portfolio - MAVENCLAD® (cladribine tablets), Rebif® (interferon beta-1a) and investigational evobrutinib - New long-term data and real-world evidence further characterise efficacy and safety of MAVENCLAD® -...

2020-09-03 20:00 2442

Taking the Pulse® 2020 Physician Survey Shows 4 in 5 U.S. Physicians Have Conducted Virtual Patient Consults Amid the COVID-19 Pandemic

New physician data from Decision Resources Group, part of Clarivate, shows pandemic mitigation measures are shifting how physicians provide care to their patients and stay informed of latest drug developments LONDON, Sept. 3, 2020 /PRNewswire/ -- Decision Resources Group (DRG), part of Clarivate...

2020-09-03 20:00 10733

Innovent Announces NMPA Granted Marketing Approval for SULINNO® (Adalimumab Injection) in China

SAN FRANCISCO, U.S. and SUZHOU, China, Sept. 3, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major ...

2020-09-03 17:50 3080

New investors Thiel and Novogratz introduced to Bionomics by Apeiron Investment Group as part of successful second placement capital raising

SYDNEY, Sept. 3, 2020 /PRNewswire/ -- Following overwhelming shareholder approval, the scheduled second placement of 54,333,000 new shares by Bionomics is proceeding and expected to complete shortly. In accordance with the Subscription Agreement between Apeiron and Bionomics, Apeiron has introduc...

2020-09-03 16:34 21817
1 ... 891011121314 ... 888